Symposium
LGBTQIA+
Charles Stewart Kamen, M.P.H., Ph.D. (he/him/his)
University of Rochester
Rochester, New York, United States
Nora Akcasu, MPH
Research Assistant
Wayne State University
Detroit, Michigan, United States
Francisco Cartujano Barrera, MD
Assistant Professor
University of Rochester
Rochester, New York, United States
Valerie Chiodo, BSN, RN
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Linda Donahue, LCSW
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Brian Holloway, BA
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Milena Insalaco, BA
Clinical Research Coordinator
University of Rochester
Rochester, New York, United States
Heidi Miller, MPH
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Lelaina Nagle, BA
Senior Clinical Research Specialist
University of Rochester
Rochester, New York, United States
Matt Poquadeck, MS
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Hayley Thompson, PhD
Professor
Wayne State University
Detroit, Michigan, United States
Karen Young, BA
Community Advisory Board Member
University of Rochester
Rochester, New York, United States
Theresa Hastert, PhD
Associate Professor
Wayne State University
Detroit, Michigan, United States
LGBTQ cancer patients and their caregivers experience disparities in cancer-related health outcomes, including health-related quality of life (QOL). Evidence-based psychoeducational and behavioral interventions to improve QOL often do not address LGBTQ-specific needs, limiting their real-world reach. Using the ADAPT-ITT framework, community stakeholders identified improving LGBTQ cancer patient/caregiver QOL as a priority and identified the dyadic FOCUS program as their preferred intervention. FOCUS was originally a nurse-led psychoeducational and behavioral intervention conducted over 5 in-person and phone-based sessions with both patients and caregivers together. We conducted 10 “theater test” focus groups with LGBTQ cancer survivors and caregivers (N = 52) to obtain suggestions for adapting the FOCUS program and enhancing its reach to LGBTQ survivors and caretakers. During the focus groups, participants were shown existing FOCUS materials and asked to provide feedback based on their personal experiences with cancer. We transcribed and coded focus group data and synthesized participants’ feedback. Participants suggested several adaptations of the FOCUS program content to better address LGBTQ cancer-related needs, including: acknowledging patients’ “chosen family”; providing information about legal issues to support unmarried partners; recognizing the impact of minority stress on psychological distress; discussing how to find LGBTQ resources, support, and health information when providers cannot answer LGBTQ-specific questions; and empowering to advocate for oneself in the face of non-affirming care. Transgender and nonbinary participants in particular recommended providing information on gender affirming care during cancer treatment and recognizing the potential impact of treatment on body image and gender identity. Participants also suggested modifications to the intervention format, including time for the patient and the caregiver to meet with the interventionist separately, delivering the intervention virtually over Zoom to improve accessibility, and having an LGBTQ or allied interventionist lead the sessions. Overall, participants endorsed the FOCUS program as a potentially efficacious intervention and provided specific modifications to meet the needs of LGBTQ cancer survivors and caregivers. Culturally-specific adaptations are not only important for establishing intervention effectiveness but also in ensuring future implementation efforts reach patients who need the most support.